BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nightingale H, Pfeffer G, Bargiela D, Horvath R, Chinnery PF. Emerging therapies for mitochondrial disorders. Brain 2016;139:1633-48. [PMID: 27190030 DOI: 10.1093/brain/aww081] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Fuentes M, Araya-maturana R, Palomo I, Fuentes E. Platelet mitochondrial dysfunction and mitochondria-targeted quinone-and hydroquinone-derivatives: Review on new strategy of antiplatelet activity. Biochemical Pharmacology 2018;156:215-22. [DOI: 10.1016/j.bcp.2018.08.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
2 Di Nora C, Paldino A, Miani D, Finato N, Pizzolitto S, De Maglio G, Vendramin I, Sponga S, Nalli C, Sinagra G, Livi U. Heart Transplantation in Kearns-Sayre Syndrome. Transplantation 2019;103:e393-4. [DOI: 10.1097/tp.0000000000002860] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liu K, Zhou Z, Pan M, Zhang L. Stem cell-derived mitochondria transplantation: A promising therapy for mitochondrial encephalomyopathy. CNS Neurosci Ther 2021;27:733-42. [PMID: 33538116 DOI: 10.1111/cns.13618] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Frazier AE, Thorburn DR, Compton AG. Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology. J Biol Chem 2019;294:5386-95. [PMID: 29233888 DOI: 10.1074/jbc.R117.809194] [Cited by in Crossref: 102] [Cited by in F6Publishing: 61] [Article Influence: 20.4] [Reference Citation Analysis]
5 Craven L, Tang MX, Gorman GS, De Sutter P, Heindryckx B. Novel reproductive technologies to prevent mitochondrial disease. Hum Reprod Update 2017;23:501-19. [PMID: 28651360 DOI: 10.1093/humupd/dmx018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
6 van den Ameele J, Hong Y, Manavaki R, Kouli A, Biggs H, MacIntyre Z, Horvath R, Yu-Wai-Man P, Reid E, Williams-Gray CH, Bullmore E, Aigbirhio F, Fryer T, Chinnery P. [11C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease. Neurology 2021:10. [PMID: 33883237 DOI: 10.1212/WNL.0000000000012033] [Reference Citation Analysis]
7 Jackson M, Marks L, May GHW, Wilson JB. The genetic basis of disease. Essays Biochem 2018;62:643-723. [PMID: 30509934 DOI: 10.1042/EBC20170053] [Cited by in Crossref: 60] [Cited by in F6Publishing: 24] [Article Influence: 15.0] [Reference Citation Analysis]
8 Al Khatib I, Shutt TE. Advances Towards Therapeutic Approaches for mtDNA Disease. Adv Exp Med Biol 2019;1158:217-46. [PMID: 31452143 DOI: 10.1007/978-981-13-8367-0_12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Marín R, Chiarello DI, Abad C, Rojas D, Toledo F, Sobrevia L. Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia. Biochim Biophys Acta Mol Basis Dis 2020;1866:165961. [PMID: 32916282 DOI: 10.1016/j.bbadis.2020.165961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 de Barcelos IP, Emmanuele V, Hirano M. Advances in primary mitochondrial myopathies. Curr Opin Neurol 2019;32:715-21. [PMID: 31408013 DOI: 10.1097/WCO.0000000000000743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Iannetti EF, Smeitink JAM, Willems PHGM, Beyrath J, Koopman WJH. Rescue from galactose-induced death of Leigh Syndrome patient cells by pyruvate and NAD.. Cell Death Dis 2018;9:1135. [PMID: 30429455 DOI: 10.1038/s41419-018-1179-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
12 Steele H, Gomez-Duran A, Pyle A, Hopton S, Newman J, Stefanetti RJ, Charman SJ, Parikh JD, He L, Viscomi C, Jakovljevic DG, Hollingsworth KG, Robinson AJ, Taylor RW, Bottolo L, Horvath R, Chinnery PF. Metabolic effects of bezafibrate in mitochondrial disease. EMBO Mol Med 2020;12:e11589. [PMID: 32107855 DOI: 10.15252/emmm.201911589] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
13 Beyrath J, Pellegrini M, Renkema H, Houben L, Pecheritsyna S, van Zandvoort P, van den Broek P, Bekel A, Eftekhari P, Smeitink JAM. KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery. Sci Rep 2018;8:6577. [PMID: 29700325 DOI: 10.1038/s41598-018-24900-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
14 Vezza T, Abad-Jiménez Z, Marti-Cabrera M, Rocha M, Víctor VM. Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes. Antioxidants (Basel) 2020;9:E848. [PMID: 32927712 DOI: 10.3390/antiox9090848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Newman NJ. Diagnosis and Management of Mitochondrial Neuro-Ophthalmologic Disorders: Translating Scientific Advances Into the Clinic. J Neuroophthalmol 2017;37:65-9. [PMID: 28187083 DOI: 10.1097/WNO.0000000000000471] [Reference Citation Analysis]
16 van den Ameele J, Fuge J, Pitceathly RDS, Berry S, McIntyre Z, Hanna MG, Lee M, Chinnery PF. Chronic pain is common in mitochondrial disease. Neuromuscul Disord 2020;30:413-9. [PMID: 32334903 DOI: 10.1016/j.nmd.2020.02.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Cunarro J, Casado S, Lugilde J, Tovar S. Hypothalamic Mitochondrial Dysfunction as a Target in Obesity and Metabolic Disease. Front Endocrinol (Lausanne) 2018;9:283. [PMID: 29904371 DOI: 10.3389/fendo.2018.00283] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
18 Patel R, Coulter LL, Rimmer J, Parkes M, Chinnery PF, Swift O. Mitochondrial neurogastrointestinal encephalopathy: a clinicopathological mimic of Crohn's disease. BMC Gastroenterol 2019;19:11. [PMID: 30646848 DOI: 10.1186/s12876-018-0925-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Murphy MP, Hartley RC. Mitochondria as a therapeutic target for common pathologies. Nat Rev Drug Discov 2018;17:865-86. [PMID: 30393373 DOI: 10.1038/nrd.2018.174] [Cited by in Crossref: 211] [Cited by in F6Publishing: 203] [Article Influence: 52.8] [Reference Citation Analysis]
20 Moretton A, Morel F, Macao B, Lachaume P, Ishak L, Lefebvre M, Garreau-Balandier I, Vernet P, Falkenberg M, Farge G. Selective mitochondrial DNA degradation following double-strand breaks. PLoS One 2017;12:e0176795. [PMID: 28453550 DOI: 10.1371/journal.pone.0176795] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 11.4] [Reference Citation Analysis]
21 van Tienen F, Zelissen R, Timmer E, van Gisbergen M, Lindsey P, Quattrocelli M, Sampaolesi M, Mulder-den Hartog E, de Coo I, Smeets H. Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy. Stem Cell Res Ther 2019;10:405. [PMID: 31864395 DOI: 10.1186/s13287-019-1510-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Mukund K, Subramaniam S. Co-expression Network Approach Reveals Functional Similarities among Diseases Affecting Human Skeletal Muscle. Front Physiol 2017;8:980. [PMID: 29249983 DOI: 10.3389/fphys.2017.00980] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sinnecker T, Andelova M, Mayr M, Rüegg S, Sinnreich M, Hench J, Frank S, Schaller A, Stippich C, Wuerfel J, Bonati LH. Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with suspected recurrent strokes - a case report. BMC Neurol 2019;19:91. [PMID: 31068171 DOI: 10.1186/s12883-019-1306-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Aravintha Siva M, Mahalakshmi R, Bhakta-Guha D, Guha G. Gene therapy for the mitochondrial genome: Purging mutations, pacifying ailments. Mitochondrion 2019;46:195-208. [PMID: 29890303 DOI: 10.1016/j.mito.2018.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Skuratovskaia D, Komar A, Vulf M, Litvinova L. Mitochondrial destiny in type 2 diabetes: the effects of oxidative stress on the dynamics and biogenesis of mitochondria. PeerJ 2020;8:e9741. [PMID: 32904391 DOI: 10.7717/peerj.9741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 La Morgia C, Maresca A, Caporali L, Valentino ML, Carelli V. Mitochondrial diseases in adults. J Intern Med 2020;287:592-608. [DOI: 10.1111/joim.13064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
27 Augustyniak J, Lenart J, Gaj P, Kolanowska M, Jazdzewski K, Stepien PP, Buzanska L. Bezafibrate Upregulates Mitochondrial Biogenesis and Influence Neural Differentiation of Human-Induced Pluripotent Stem Cells. Mol Neurobiol 2019;56:4346-63. [PMID: 30315479 DOI: 10.1007/s12035-018-1368-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
28 Karaa A, Rahman S, Lombès A, Yu-Wai-Man P, Sheikh MK, Alai-Hansen S, Cohen BH, Dimmock D, Emrick L, Falk MJ, McCormack S, Mirsky D, Moore T, Parikh S, Shoffner J, Taivassalo T, Tarnopolsky M, Tein I, Odenkirchen JC, Goldstein A; Mito Working Group Member Participants:. Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project. J Inherit Metab Dis 2017;40:403-14. [PMID: 28303425 DOI: 10.1007/s10545-017-0035-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
29 Douiev L, Soiferman D, Alban C, Saada A. The Effects of Ascorbate, N-Acetylcysteine, and Resveratrol on Fibroblasts from Patients with Mitochondrial Disorders. J Clin Med 2016;6:E1. [PMID: 28025489 DOI: 10.3390/jcm6010001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
30 Heaton R, Millichap L, Saleem F, Gannon J, Begum G, Hargreaves IP. Current biochemical treatments of mitochondrial respiratory chain disorders. Expert Opinion on Orphan Drugs 2019;7:277-85. [DOI: 10.1080/21678707.2019.1638250] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Perli E, Pisano A, Pignataro MG, Campese AF, Pelullo M, Genovese I, de Turris V, Ghelli AM, Cerbelli B, Giordano C, Colotti G, Morea V, d'Amati G. Exogenous peptides are able to penetrate human cell and mitochondrial membranes, stabilize mitochondrial tRNA structures, and rescue severe mitochondrial defects. FASEB J 2020;34:7675-86. [PMID: 32304340 DOI: 10.1096/fj.201903270R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Fabbri A, Travaglione S, Maroccia Z, Guidotti M, Pierri CL, Primiano G, Servidei S, Loizzo S, Fiorentini C. The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study. Int J Mol Sci 2018;19:E1825. [PMID: 29933571 DOI: 10.3390/ijms19071825] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
33 Fan F, Sam R, Ryan E, Alvarado K, Villa-Cuesta E. Rapamycin as a potential treatment for succinate dehydrogenase deficiency. Heliyon 2019;5:e01217. [PMID: 30805566 DOI: 10.1016/j.heliyon.2019.e01217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
34 Ahuja AS. Understanding mitochondrial myopathies: a review. PeerJ 2018;6:e4790. [PMID: 29844960 DOI: 10.7717/peerj.4790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]